Growth Metrics

Baxter International (BAX) Current Deferred Revenue (2021 - 2023)

Baxter International (BAX) has disclosed Current Deferred Revenue for 3 consecutive years, with $169.0 million as the latest value for Q4 2023.

  • Quarterly Current Deferred Revenue fell 2.31% to $169.0 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $169.0 million through Dec 2023, down 2.31% year-over-year, with the annual reading at $169.0 million for FY2023, 2.31% down from the prior year.
  • Current Deferred Revenue for Q4 2023 was $169.0 million at Baxter International, down from $173.0 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $196.0 million in Q4 2021, with the low at $169.0 million in Q4 2023.
  • Average Current Deferred Revenue over 3 years is $179.3 million, with a median of $173.0 million recorded in 2022.
  • The sharpest move saw Current Deferred Revenue dropped 11.73% in 2022, then dropped 2.31% in 2023.
  • Over 3 years, Current Deferred Revenue stood at $196.0 million in 2021, then dropped by 11.73% to $173.0 million in 2022, then decreased by 2.31% to $169.0 million in 2023.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $169.0 million, $173.0 million, and $196.0 million for Q4 2023, Q4 2022, and Q4 2021 respectively.